Steve R. Turner
Publications by Year
Research Areas
HIV/AIDS drug development and treatment, Renin-Angiotensin System Studies, HIV Research and Treatment, Chemical Synthesis and Analysis, Pneumocystis jirovecii pneumonia detection and treatment
Most-Cited Works
- → Tipranavir (PNU-140690): A Potent, Orally Bioavailable Nonpeptidic HIV Protease Inhibitor of the 5,6-Dihydro-4-hydroxy-2-pyrone Sulfonamide Class(1998)295 cited
- → Design and synthesis of potent and specific renin inhibitors containing difluorostatine, difluorostatone, and related analogs(1986)134 cited
- → Structure-Based Design of Novel HIV Protease Inhibitors: Carboxamide-Containing 4-Hydroxycoumarins and 4-Hydroxy-2-pyrones as Potent Nonpeptidic Inhibitors(1995)121 cited
- → Structure-Based Design of HIV Protease Inhibitors: Sulfonamide-Containing 5,6-Dihydro-4-hydroxy-2-pyrones as Non-Peptidic Inhibitors(1996)96 cited
- → Structure-Based Design of Novel HIV Protease Inhibitors: Sulfonamide-Containing 4-Hydroxycoumarins and 4-Hydroxy-2-pyrones as Potent Non-Peptidic Inhibitors(1996)88 cited
- → Structure-Based Design of HIV Protease Inhibitors: 5,6-Dihydro-4-hydroxy-2-pyrones as Effective, Nonpeptidic Inhibitors(1996)86 cited
- → Renin inhibitors. Design of angiotensinogen transition-state analogs containing novel (2R,3R,4R,5S)-5-amino-3,4-dihydroxy-2-isopropyl-7-methyloctanoic acid(1987)71 cited
- → Difluorostatine and difluorostatone containing peptides as potent and specific renin inhibitors(1985)65 cited
- → Conformationally constrained renin inhibitory peptides: .gamma.-lactam-bridged dipeptide isostere as conformational restriction(1988)62 cited
- → Design and synthesis of a potent and specific renin inhibitor with a prolonged duration of action in vivo(1986)52 cited